Viatris Inc.SEC Filings
|
|
All SEC filings by Viatris Inc. (VTRS) — annual and quarterly reports, current reports, registrations, proxies and ownership forms, updated in real time.
Financials
| 10-Q | Quarterly report | View Diff | Aug 6, 2026 | |
| 10-Q | Quarterly report | View Diff | May 7, 2026 | |
| ARS | Annual report to shareholders | Apr 2, 2026 | ||
| 10-K | Annual report | View Diff | Feb 26, 2026 | |
| 10-Q | Quarterly report | View Diff | Nov 6, 2025 | |
| ARS | Annual report to shareholders | Oct 24, 2025 | ||
| 10-Q | Quarterly report | View Diff | Aug 7, 2025 | |
| 10-Q | Quarterly report | View Diff | May 8, 2025 | |
| 10-K/A | Annual report | View Diff | Apr 30, 2025 | |
| 10-K | Annual report | View Diff | Feb 27, 2025 |
Events
| 8-K | Viatris Agrees to Acquire Pacira Biosciences, Advancing Its Innovative Medicines Strategy and Becoming a Leader in Non-Opioid Pain Therapies | Oct 8, 2026 | ||
| 8-K | Viatris Reports Second-Quarter 2026 Financial Results | Aug 6, 2026 | ||
| 8-K | Current report | Jul 1, 2026 | ||
| 8-K | Current report | Jun 18, 2026 | ||
| 8-K | Current report | Jun 15, 2026 | ||
| 8-K | Submission of Matters to a Vote of Security Holders | May 15, 2026 | ||
| 8-K | Viatris Reports First-Quarter 2026 Financial Results | May 7, 2026 | ||
| 8-K | Viatris Announces Chief Financial Officer Transition | May 4, 2026 | ||
| 8-K | Viatris Reports Fourth-Quarter and Full-Year 2025 Financial Results | Feb 26, 2026 | ||
| 8-K | Departure of Directors or Certain Officers | Feb 3, 2026 |
Registrations and Prospectuses
| SC TO-C | Information about tender offer | Oct 8, 2026 | ||
| SC TO-C | Information about tender offer | Oct 8, 2026 | ||
| 424B5 | Prospectus supplement for primary offering | Jun 15, 2026 | ||
| FWP | Free writing prospectus | Jun 12, 2026 | ||
| FWP | Free writing prospectus | Jun 12, 2026 | ||
| 424B5 | Prospectus supplement for primary offering | Jun 12, 2026 | ||
| S-3ASR | Automatic shelf registration | May 8, 2025 | ||
| S-8 | Registration of securities for employees | Mar 3, 2023 | ||
| SC TO-T/A | Third party tender offer statement | Jan 3, 2023 | ||
| SC TO-T/A | Third party tender offer statement | Dec 9, 2022 |
Proxies
| DEFA14A | Proxy Filing | Apr 2, 2026 | ||
| DEF 14A | Annual Meeting of Shareholders | View Diff | Apr 2, 2026 | |
| DEFA14A | Additional proxy soliciting materials | Oct 24, 2025 | ||
| DEF 14A | Definitive proxy | View Diff | Oct 24, 2025 | |
| DEFA14A | Additional proxy soliciting materials | Oct 25, 2024 | ||
| DEF 14A | Definitive proxy | View Diff | Oct 25, 2024 | |
| DEFA14A | Additional proxy soliciting materials | Nov 24, 2023 | ||
| DEFA14A | Additional proxy soliciting materials | Nov 3, 2023 | ||
| DEF 14A | Definitive proxy | View Diff | Nov 3, 2023 | |
| PRE 14A | Preliminary proxy | Oct 24, 2023 |
Other
| UPLOAD | Letter from SEC | Aug 24, 2022 | ||
| CORRESP | Correspondence with SEC | Aug 8, 2022 | ||
| UPLOAD | Letter from SEC | Jul 27, 2022 | ||
| EFFECT | Notice of effectiveness | Sep 29, 2021 | ||
| CORRESP | Correspondence with SEC | Sep 24, 2021 | ||
| UPLOAD | Letter from SEC | Sep 17, 2021 | ||
| CERT | Certification of approval for exchange listing | Nov 10, 2020 | ||
| SEC STAFF | SEC staff action: Order | Jun 30, 2020 | ||
| EFFECT | Notice of effectiveness | Feb 14, 2020 | ||
| CORRESP | Correspondence with SEC | Feb 11, 2020 |
Ownership
| 4 | Groothuis Leo Frans | Oct 2, 2026 | ||
| 4 | Simmons David S | Oct 2, 2026 | ||
| SC 13G/A | Fmr Llc Updates Stake in Viatris Inc | Sep 8, 2026 | ||
| 4 | Enrietti Andrew | Aug 18, 2026 | ||
| SC 13G/A | Davis Selected Advisers Updates Stake in Viatris Inc | Aug 12, 2026 | ||
| SC 13G | Fmr Llc Acquires 8.3% Stake in Viatris Inc | Aug 6, 2026 | ||
| 4 | Simmons David S | Jul 1, 2026 | ||
| 4 | Groothuis Leo Frans | Jul 1, 2026 | ||
| 4 | Campbell Paul | Jun 26, 2026 | ||
| 144 | Notice of proposed sale of securities | Jun 25, 2026 |